Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial
- Dale Bixby,
- Richard Noppeney,
- Tara L. Lin,
- ,
- Jürgen Krauter,
- Karen Yee
- University of Michigan, Ann Arbor,
- University of Duisburg-Essen,
- University of Kansas,
- University of Texas MD Anderson Cancer Center,
- Städtisches Klinikum Braunschweig gGmbH,
- Princess Margaret Hospital
Scholary Output:
Contribution to journal
Letter
Peer-review
Open access
Publication Information
Output type
Scholary Output:
Contribution to journal
Letter
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 595-598 (4 pages)Journal (Volume, Issue Number)
British Journal of Haematology (Volume 185, Issue 3)Publication milestones
- Published - 05/2019
Publication status
Published - 05/2019
ISSN
0007-1048Publication IDs
- Scopus: 85053031522
- PubMed: 30203489
- ORCID: /0000-0002-8636-1071/work/68887892
Publication metrics
Metrics
SciVal
citations
8
SciVal
FWCI
3.01
SciVal
Author count
14
SciVal
Paper percentile
85
Fractional count
1
Fractional count
0.07
Fractional count
13
Fractional count
0.93
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
13
Citation count
21
Funding Details
This study was funded by F. Hoffman-La Roche, Ltd. Medical writing support was provided by Lucy Smithers, PhD (ApotheCom, London, UK), which was funded by F. Hoffmann-La Roche Ltd.